• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

European migration crises: The role of national hemoglobinopathy registries in improving patient access to care.

作者信息

Inusa Baba P D, Colombatti Raffaella

机构信息

Department of Paediatric Haematology, Evelina London Children's Hospital, Guy's and St Thomas NHS Trust, London, United Kingdom.

Clinic of Pediatric Hematology Oncology, Department of Child and Maternal Health, Azienda Ospedaliera-Università di Padova, Italy.

出版信息

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26515. Epub 2017 Mar 30.

DOI:10.1002/pbc.26515
PMID:28371007
Abstract
摘要

相似文献

1
European migration crises: The role of national hemoglobinopathy registries in improving patient access to care.欧洲移民危机:国家血红蛋白病登记处对改善患者医疗服务可及性的作用。
Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26515. Epub 2017 Mar 30.
2
National registry of hemoglobinopathies in Spain (REPHem).西班牙血红蛋白病国家登记处(REPHem)。
Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26322. Epub 2016 Nov 2.
3
The registry and surveillance in hemoglobinopathies: improving the lives of individuals with hemoglobinopathies.血红蛋白病的登记与监测:改善血红蛋白病患者的生活。
Am J Prev Med. 2010 Apr;38(4 Suppl):S510-1. doi: 10.1016/j.amepre.2010.01.005.
4
Quality assurance in melanoma care: The EU-MELACARE study.黑色素瘤护理质量保证:EU-MELACARE 研究。
Eur J Surg Oncol. 2018 Nov;44(11):1773-1778. doi: 10.1016/j.ejso.2018.06.020. Epub 2018 Jul 3.
5
Good practice guidelines for laboratory investigation of hemoglobinopathies.血红蛋白病实验室检查的良好实践指南。
Lab Hematol. 2003;9(4):237-45.
6
[Prevention of hemoglobinopathies in non-endemic countries].[非流行国家血红蛋白病的预防]
Bull Soc Pathol Exot. 2001 May;94(2):98-100.
7
A description of health care provision and access to treatment for women with urinary incontinence in Europe -- a five-country comparison.欧洲女性尿失禁患者的医疗保健服务及治疗可及性描述——五国比较
Maturitas. 2005 Nov 30;52 Suppl 2:S3-12. doi: 10.1016/j.maturitas.2005.09.007. Epub 2005 Nov 16.
8
Stroke in the young: access to care and outcome; a Western versus eastern European perspective.青年卒中:医疗可及性与结局;西欧与东欧视角
J Stroke Cerebrovasc Dis. 2008 Nov-Dec;17(6):360-5. doi: 10.1016/j.jstrokecerebrovasdis.2008.04.002.
9
EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluation.欧洲课程:欧洲基于人群的癌症登记处及其项目负责人的经验教训:通过公共卫生和临床评估的研究规划提高绩效。
Eur J Cancer. 2015 Jun;51(9):997-1017. doi: 10.1016/j.ejca.2015.02.018. Epub 2015 May 5.
10
Hemoglobinopathy control program in Turkey.土耳其的血红蛋白病控制项目。
Community Genet. 2006;9(2):124-6. doi: 10.1159/000091493.

引用本文的文献

1
Newborn Screening for Sickle Cell Disease: Results from a Pilot Study in the Portuguese Population.镰状细胞病的新生儿筛查:葡萄牙人群试点研究结果
Int J Neonatal Screen. 2025 Jan 27;11(1):10. doi: 10.3390/ijns11010010.
2
Zinc level and effect of zinc supplementation on growth in a subset of Sudanese children with sickle cell disease.苏丹患有镰状细胞病儿童亚组的锌水平及补锌对其生长的影响。
Sudan J Paediatr. 2023;23(2):214-223. doi: 10.24911/SJP.106-1638821311.
3
Sickle cell disease: embedding patient participation into an international conference can transform the role of lived experience.
镰状细胞病:将患者参与融入国际会议可以改变患者经验的作用。
Orphanet J Rare Dis. 2023 Nov 1;18(1):341. doi: 10.1186/s13023-023-02951-8.
4
Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease.治疗地中海贫血症和镰状细胞病患儿及青少年的新视角。
Eur J Pediatr. 2023 Jun;182(6):2509-2519. doi: 10.1007/s00431-023-04900-w. Epub 2023 Mar 31.
5
Differences in the distribution of hemoglobin variants according to the geographic regions in a Colombian population.哥伦比亚人群中血红蛋白变体分布根据地理区域的差异。
Hematol Transfus Cell Ther. 2023 Jul;45 Suppl 2(Suppl 2):S140-S147. doi: 10.1016/j.htct.2022.11.012. Epub 2023 Jan 31.
6
Health-related quality of life in hemoglobinopathies: A systematic review from a global perspective.血红蛋白病患者与健康相关的生活质量:一项全球视角的系统综述。
Front Pediatr. 2022 Aug 25;10:886674. doi: 10.3389/fped.2022.886674. eCollection 2022.
7
Distribution of HbS Allele and Haplotypes in a Multi-Ethnic Population of Guinea Bissau, West Africa: Implications for Public Health Screening.西非几内亚比绍多民族人群中血红蛋白S等位基因和单倍型的分布:对公共卫生筛查的启示
Front Pediatr. 2022 Apr 7;10:826262. doi: 10.3389/fped.2022.826262. eCollection 2022.
8
Immigration and screening programs for hemoglobinopathies in Italy, Spain and Turkey.意大利、西班牙和土耳其的血红蛋白病移民和筛查计划。
Acta Biomed. 2021 Sep 2;92(4):e2021410. doi: 10.23750/abm.v92i4.11965.
9
Annual Academy of Sickle Cell and Thalassaemia (ASCAT) conference: a summary of the proceedings.镰状细胞与地中海贫血学会(ASCAT)年度会议:会议纪要
BMC Proc. 2020 Dec 16;14(Suppl 20):21. doi: 10.1186/s12919-020-00204-1.
10
Sickle Cell Disease-Genetics, Pathophysiology, Clinical Presentation and Treatment.镰状细胞病——遗传学、病理生理学、临床表现与治疗
Int J Neonatal Screen. 2019 May 7;5(2):20. doi: 10.3390/ijns5020020. eCollection 2019 Jun.